ArticleLeukemia2017
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
M O Holmström et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papercites it
ArticleLeukemia2017
M O Holmström et al.PubMed ↗Publisher ↗
No numbers read from the abstract.